• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因早期多发且完全性支架内断裂致急性冠状动脉综合征:病例报告并文献复习简评。

Acute coronary syndrome due to early multiple and complete fractures in sirolimus-eluting stent: a case report and brief literature review.

机构信息

Cardiology Unit, S. Elia Hospital, Caltanissetta, Italy.

出版信息

Catheter Cardiovasc Interv. 2013 Jan 1;81(1):52-6. doi: 10.1002/ccd.24414. Epub 2012 May 2.

DOI:10.1002/ccd.24414
PMID:22431372
Abstract

Despite drug eluting stents (DES), as compared to bare metal stents, have reduced in-stent restenosis, complex and long lesions remains a challenge for interventional cardiologist. Their treatment is often associated with an unfavorable outcome, related to in-stent restenosis, stent thrombosis, and target lesion revascularization. These complications may derive from the contact between metallic structures and coronary artery endothelium, and consequent overexpression of platelet activating factors, growth factors, and inflammatory cytokines. Recently, an additional mechanism has emerged as new cause of these complications: "stent fracture." Several factors are involved in this phenomenon including material and stent platform, target vessel features, stent implantation technique, and implant duration. We reported a case of 69 years old man with rare early and complex DES fractures on right coronary that caused acute coronary syndrome 36 hr after a previous percutaneous coronary intervention.

摘要

尽管药物洗脱支架(DES)与裸金属支架相比,已经降低了支架内再狭窄的发生率,但复杂且长的病变仍然是介入心脏病学家面临的挑战。这些病变的治疗往往与不利的结果相关,包括支架内再狭窄、支架血栓形成和靶病变血运重建。这些并发症可能源于金属结构与冠状动脉内皮之间的接触,以及随后血小板激活因子、生长因子和炎症细胞因子的过度表达。最近,一种新的并发症机制出现了:“支架断裂”。多种因素参与了这一现象,包括材料和支架平台、靶血管特征、支架植入技术和植入持续时间。我们报告了一例 69 岁男性,在先前经皮冠状动脉介入治疗 36 小时后,因右冠状动脉罕见的早期和复杂 DES 断裂导致急性冠状动脉综合征。

相似文献

1
Acute coronary syndrome due to early multiple and complete fractures in sirolimus-eluting stent: a case report and brief literature review.因早期多发且完全性支架内断裂致急性冠状动脉综合征:病例报告并文献复习简评。
Catheter Cardiovasc Interv. 2013 Jan 1;81(1):52-6. doi: 10.1002/ccd.24414. Epub 2012 May 2.
2
Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.SPIRIT FIRST 试验:依维莫司洗脱 XIENCE V 冠状动脉支架系统治疗初发冠状动脉病变患者的 5 年临床随访。
Catheter Cardiovasc Interv. 2010 Jun 1;75(7):997-1003. doi: 10.1002/ccd.22428.
3
Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.药物洗脱支架植入术后左主干远端/分叉处再狭窄的管理:单中心经验
Cardiovasc Revasc Med. 2014 Mar;15(2):76-9. doi: 10.1016/j.carrev.2014.01.008. Epub 2014 Jan 20.
4
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.在接受西罗莫司洗脱支架或紫杉醇洗脱支架治疗的未经选择的经皮冠状动脉介入治疗患者中的院内及1年结局:EVENT(药物洗脱支架与缺血事件评估)注册研究结果
JACC Cardiovasc Interv. 2009 Aug;2(8):767-75. doi: 10.1016/j.jcin.2009.05.016.
5
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.随机评价两种药物洗脱支架,它们具有相同的金属平台和可生物降解聚合物,但药物不同(紫杉醇或西罗莫司),与裸支架相比:PAINT 试验的 1 年结果。
Catheter Cardiovasc Interv. 2009 Nov 1;74(5):665-73. doi: 10.1002/ccd.22166.
6
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).药物洗脱球囊与依维莫司洗脱支架治疗金属裸支架内再狭窄的随机对照研究:RIBS V 临床试验(金属裸支架内再狭窄:紫杉醇洗脱球囊与依维莫司洗脱支架)。
J Am Coll Cardiol. 2014 Apr 15;63(14):1378-86. doi: 10.1016/j.jacc.2013.12.006. Epub 2014 Jan 8.
7
Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.紫杉醇洗脱支架与西罗莫司洗脱支架相比,支架断裂相关再狭窄风险降低:长期随访结果。
Catheter Cardiovasc Interv. 2012 Mar 1;79(4):559-65. doi: 10.1002/ccd.23031. Epub 2011 May 12.
8
A completely fractured zotarolimus-eluting stent in an aortocoronary saphenous vein bypass graft.完全断裂的佐他莫司洗脱支架在冠状动脉隐静脉旁路移植术中。
Catheter Cardiovasc Interv. 2013 Jan 1;81(1):62-5. doi: 10.1002/ccd.24312. Epub 2012 May 2.
9
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.经皮冠状动脉介入治疗后病变长度和血管大小对临床结局的影响:来自 SPIRIT(依维莫司洗脱冠状动脉支架系统 XIENCE V 的临床评估)和 COMPARE(真实世界中第二代依维莫司洗脱和紫杉醇洗脱支架)随机试验的汇总分析。
JACC Cardiovasc Interv. 2011 Nov;4(11):1209-15. doi: 10.1016/j.jcin.2011.07.016.
10
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.用于治疗冠状动脉开口病变的药物洗脱支架:西罗莫司洗脱支架与紫杉醇洗脱支架的比较
Coron Artery Dis. 2008 Nov;19(7):507-11. doi: 10.1097/MCA.0b013e32830936d4.

引用本文的文献

1
An Interesting Case and Literature Review of a Coronary Stent Fracture in a Current Generation Platinum Chromium Everolimus-Eluting Stent.当代铂铬依维莫司洗脱支架冠状动脉支架断裂的一个有趣病例及文献综述
Case Rep Cardiol. 2018 Jun 4;2018:4579184. doi: 10.1155/2018/4579184. eCollection 2018.
2
Two cases of immediate stent fracture after zotarolimus-eluting stent implantation.两例在使用依维莫司洗脱支架后立即发生支架断裂。
Korean Circ J. 2015 Jan;45(1):67-70. doi: 10.4070/kcj.2015.45.1.67. Epub 2015 Jan 26.